1. Home
  2. INMD vs CDNA Comparison

INMD vs CDNA Comparison

Compare INMD & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

N/A

Current Price

$12.76

Market Cap

842.0M

Sector

Health Care

ML Signal

N/A

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$16.45

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INMD
CDNA
Founded
2008
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.0M
1.0B
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
INMD
CDNA
Price
$12.76
$16.45
Analyst Decision
Hold
Buy
Analyst Count
6
7
Target Price
$16.75
$27.33
AVG Volume (30 Days)
832.3K
551.4K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,324,000.00
Revenue This Year
$1.70
$15.37
Revenue Next Year
$3.99
$11.23
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
18.93
52 Week Low
$12.95
$10.96
52 Week High
$19.09
$21.49

Technical Indicators

Market Signals
Indicator
INMD
CDNA
Relative Strength Index (RSI) 29.67 30.56
Support Level N/A $14.09
Resistance Level $14.80 $20.94
Average True Range (ATR) 0.27 0.83
MACD -0.10 -0.25
Stochastic Oscillator 0.31 1.90

Price Performance

Historical Comparison
INMD
CDNA

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: